December 2, 2024: 1,300 More People File Rybelsus and Other GLP-1 Lawsuits in November The multidistrict litigation lawsuit (MDL) against Rybelsus manufacturer Novo Nordisk and other GLP-1 manufacturers has 1,300 pending lawsuits as of December 2, 2024
This is not only about following rules, but about making sure the medication you rely on is as effective as possible
Yes, semaglutide can lead to significant weight loss, improved metabolic health, and better management of type 2 diabetes
however, semaglutide frequently has higher effectiveness at lower dosages
However, early responders during (those that lost more than 10% of their starting weight by week 16) saw an average weight loss of 22% by the end of the trial